Progress in skin gene therapy: From the inside and out
Open Access
- 12 March 2025
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 33 (5) , 2065-2081
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
This publication has 184 references indexed in Scilit:
- Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis BullosaJAMA Dermatology, 2024
- Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis BullosaJAMA Dermatology, 2023
- Dual gene‐activated dermal scaffolds regulate angiogenesis and wound healing by mediating the coexpression of VEGF and angiopoietin‐1Bioengineering & Translational Medicine, 2023
- Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA NanoparticlesAdvanced Materials, 2019
- Efficacy of Human Placental-Derived Stem Cells in Collagen VII Knockout (Recessive Dystrophic Epidermolysis Bullosa) Animal ModelStem Cells Translational Medicine, 2018
- Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis BullosaJAMA, 2016
- Rescue of the Mucocutaneous Manifestations by Human Cord Blood Derived Nonhematopoietic Stem Cells in a Mouse Model of Recessive Dystrophic Epidermolysis BullosaStem Cells, 2015
- Engineering HSV-1 Vectors for Gene Therapy2014
- Herpes simplex virus gene products: the accessories reflect her lifestyle wellReviews in Medical Virology, 2004
- Structural Organization of the Human Type VII Collagen Gene (COL7A1), Composed of More Exons Than Any Previously Characterized GeneGenomics, 1994